Results of Ukrain monotherapy of prostate cancer

Drugs under Experimental and Clinical Research

Volumn 26, Issue 5-6, 2000, Pages 191-193

  Uglyanitsa, K N ^a   Nechiporenko, N A ^a   Nefyodov, L I ^a   Doroshenko, Y M ^a   Brzosko, W ^a   Nowicky, W ^a  

^a GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

UKRAIN;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HELPER CELL; HUMAN; HUMAN TISSUE; MALE; PROSTATE CARCINOMA; SUPPRESSOR CELL; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE ALKALOIDS; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; PHENANTHRIDINES; PROSTATIC NEOPLASMS;

EID: 0034448773     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain
2. Enhancement of cell mediated lysis on tumor cells by Chelidonium majus L. alkaloids (Ukrain)
3. The malignotoxic and immune modulating property of the alkaloid derivative Ukrain
4. In vitro effect of thiophosphoric acid derivatives from Chelidonium majus L. on normal lymphocyte subpopulation
5. Biological and physiological effects of Ukrain
6. Evaluation of clinical studies of Ukrain in cancer patients
7. Preliminary report on clinical experience in the use of Ukrain
8. Clinical studies of Ukrain in terminal cancer patients (phase II)
9. Chelidonium majus L. (Ukrain) in the treatment of cancer patients